Patient Finding with AIML: Increasing Targeting Precision and Field Force Pull Through

Home / Intelligence / Webinars / Patient Finding with AIML: Increasing Targeting Precision and Field Force Pull Through

Available On Demand

There are four key pieces to Patient Finding:

  1. Identifying, collating and integrating the right data
  2. Defining the appropriate test population
  3. Building the right features in the model
  4. Planning and executing actions once you’ve found the patients

All four are crucial to successfully find patients. Join Adrienne Lovink, Partner and Head of Real-World Evidence (RWE) at Trinity Life Sciences, as she hosts a lively discussion on the ins and outs of Patient Finding with Trinity panelists Steve Laux, Vice President of Commercial Insights & Advanced Analytics, Nabha Subramanya, Vice President of Data Science and Sri Saikumar, Associate Principal.

Key Webinar Topics

  • Common challenges and pitfalls
  • Mitigation strategies and tips
  • Case study exploration and best practice approaches

Featuring


Complete the form below to view the on-demand webinar.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.

Gartner, Hype Cycle for Life Science Commercial Operations, 2023, Animesh Gandhi, 20 July 2023.

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, Hype Cycle is a registered trademark of Gartner, Inc. and/or its affiliates and is used herein with permission. All rights reserved.

Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s Research & Advisory organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

This webinar will be hosted within the ON24 platform, which requires the usage of Javascript and Cookies. Please see ON24’s Privacy Policy for more information.

Related Intelligence

Webinars

Omnichannel Orchestration After Patient Finding: Once You’ve Found The Patients, What Do You Do?

March 7, 2024 | 1:00 – 1:45 PM ET

Across life sciences commercialization organizations, attention is shifting to best practices in strengthening the connection between healthcare professionals (HCPs) and patients. Join Susheel Sukhtankar, Partner and Head of Commercial Analytics at Trinity Life Sciences, as he hosts a dynamic discussion on the nuances of omnichannel orchestration with panelists Jerry Luciano, Vice President of Omnichannel Marketing […]

 Sign Up Now

Blog

Insights & Analytics in Life Sciences: How to Embrace a Future with Generative AI

First, A Few Potentially Unsettling Truths Broader Context & Concerns From our industry benchmarking research, we know that GenAI is seen as the biggest trend for 2024 in pharma Insights & Analytics (I&A). There is massive pressure from stakeholders, senior management and even board members to do something with GenAI—and constant questions about creating and […]

 Read More

Blog

Key Takeaways and Learnings from ISPOR Europe 2023

Trinity Life Sciences recently attended the ISPOR Europe 2023 conference in Copenhagen, Denmark. The main theme of the conference was “HEOR at the Nexus of Policy and Science,” and the event featured unique discussions and workshops across different stakeholders from both academics and the life sciences industry, including manufacturers, regulatory leaders and health economists, to […]

 Read More